Literature DB >> 30242590

Genotoxicity and Embryotoxicity Study of Bicyclol Methyl Ether, Main Impurity in Bicyclol.

Qian-Qian Zhang1, Qiang Li2, Lin Dong3, Wan-Fang Li1, Chao Li3, Ai-Ping Wang1,3, Jin-Feng Wei1,3, Hong-Tao Jin4,5.   

Abstract

OBJECTIVE: To assess the genotoxicity and embryotoxicity of bicyclol methyl ether (BME), the main impurity in bicyclol.
METHODS: Five concentrations of BME (0.5, 5, 50, 500 and 5000 μg/plate) were used in the Ames test to detect gene mutation. In the chromosome aberration test, Chinese hamster lung cells were used to detect chromosomal aberration of BME (15, 30, 60, 120 μg/mL) with or without S9 mixture. Embryotoxicity test was also conducted to determine any embryotoxicity of BME (7.5, 22.5, 67.5 μg/L) using zebrafish embryos.
RESULTS: No significant differences were observed in the Ames test and the chromosome aberration test in the BME groups compared with the vehicle control group. The zebrafish embryos toxicity test also showed no embryo development toxicity of BME, including hatching rate, body length, pericardial area and yolk sac area.
CONCLUSIONS: Bicyclol methyl ether has no genotoxicity in vitro and embryotoxicity in zebrafish embryos, and the impurity in bicyclol is qualified.

Entities:  

Keywords:  Ames test; bicyclol methyl ether; chromosome aberration test; embryotoxicity; genotoxicity; zebrafish

Mesh:

Substances:

Year:  2018        PMID: 30242590     DOI: 10.1007/s11655-018-2553-x

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  14 in total

1.  The in vitro mammalian chromosome aberration test.

Authors:  Gill Clare
Journal:  Methods Mol Biol       Date:  2012

2.  Comparative evaluation of the in vitro micronucleus test and the in vitro chromosome aberration test: industrial experience.

Authors:  B Miller; S Albertini; F Locher; V Thybaud; E Lorge
Journal:  Mutat Res       Date:  1997-08-01       Impact factor: 2.433

3.  Therapeutic effects of biphenyl dimethyl dicarboxylate (DDB) on chronic viral hepatitis B.

Authors:  G T Liu
Journal:  Proc Chin Acad Med Sci Peking Union Med Coll       Date:  1987

4.  Toxicity of novel anti-hepatitis drug bicyclol: a preclinical study.

Authors:  Geng-Tao Liu; Yan Li; Huai-Ling Wei; Hong Lu; Hui Zhang; Yu-Gui Gao; Ling-Zhi Wang
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

5.  [Protective effect of bicyclol on concanavalin A-induced liver nuclear DNA injury in mice].

Authors:  D Zhao; G Liu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2001-07-25

Review 6.  Bicyclol: a novel drug for treating chronic viral hepatitis B and C.

Authors:  Geng Tao Liu
Journal:  Med Chem       Date:  2009-01       Impact factor: 2.745

7.  [Effect of bicyclol on acetaminophen-induced hepatotoxicity: energetic metabolism and mitochondrial injury in acetaminophen-intoxicated mice].

Authors:  Y Li; G W Dai; Y Li; G T Liu
Journal:  Yao Xue Xue Bao       Date:  2001-10

8.  Protective effects of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate on damages of isolated rat hepatocytes induced by carbon tetrachloride and D-galactosamine.

Authors:  T Fu; G Liu
Journal:  Biomed Environ Sci       Date:  1992-09       Impact factor: 3.118

9.  Genotoxicity evaluation of Guibi-Tang extract using an in vitro bacterial reverse mutation assay, chromosome aberration assay, and in vivo micronucleus test.

Authors:  Mee-Young Lee; Chang-Seob Seo; Ji-Young Kim; Hyeun-Kyoo Shin
Journal:  BMC Complement Altern Med       Date:  2014-07-01       Impact factor: 3.659

10.  Developmental toxicity of diclofenac and elucidation of gene regulation in zebrafish (Danio rerio).

Authors:  Jia-Bin Chen; Hong-Wen Gao; Ya-Lei Zhang; Yong Zhang; Xue-Fei Zhou; Chun-Qi Li; Hai-Ping Gao
Journal:  Sci Rep       Date:  2014-05-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.